|
|
Previous Article | Table of Contents | Next Article 
Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human
blood platelets
Y Miyakawa, A Oda, BJ Druker, K Ozaki, M Handa, H Ohashi and Y Ikeda
Department of Internal Medicine and Blood Center, Keio University,
Shinjuku-ku, Tokyo, Japan.
Thrombopoietin has an essential role in megakaryopoiesis and
thrombopoiesis. To investigate the signaling processes induced by
thrombopoietin, we have employed human platelets and recently demonstrated
that thrombopoietin induces rapid tyrosine phosphorylation of Jak-2, Tyk2,
Shc, Stat3, Stat5, p120(c-cbl) and other proteins in human platelets.
Because the apparent molecular weight of a major tyrosine phosphorylated
protein in platelets stimulated by thrombopoietin is approximately 85 to 95
kD, we examined the possibility that this could be Vav, a 95-kD
proto-oncogene product. Specific antisera against Vav recognized the same
95 kD protein in lysates of Jurkat cells, which are known to express Vav,
and platelets, indicating that platelets have Vav. Thrombopoietin induced
rapid tyrosine phosphorylation of Vav in platelets without an elevation in
cytosolic free calcium concentration or activation of protein kinase C. Vav
was also tyrosine phosphorylated upon treatment of platelets with thrombin,
collagen, or U46619, which activate phospholipase C, leading to an
increased ionized calcium concentration and activation of protein kinase C.
Ionomycin or phorbol 12-myristate 13-acetate (PMA) also induces tyrosine
phosphorylation of Vav, suggesting that an increase in ionized calcium
concentration or activation of protein kinase C may lead to phosphorylation
of Vav. Thrombopoietin also induced tyrosine phosphorylation of Vav in
FDCP-2 cells, genetically engineered to express human c-Mpl (FDCP-hMpl5).
However, neither ionomycin nor PMA induced an increase in tyrosine
phosphorylation of Vav in FDCP-hMpl5 cells, suggesting that the calcium and
protein kinase C pathways of Vav phosphorylation may be unique to
platelets. Further, Vav became incorporated into the Triton X-100 insoluble
10,000 g sedimentable residue in an aggregation-dependent manner,
suggesting that it may have a regulatory role in platelet cytoskeletal
processes. Vav was constitutively associated with a 28-kD adapter protein,
Grb2, which is also incorporated into the cytoskeleton in an
aggregation-dependent fashion. Lastly, we found that Vav is cleaved when
there is activation of calpain, a protease that may have a role in
postaggregation signaling processes. Our data suggest that thrombopoietin
and other agonists may induce tyrosine phosphorylation of Vav by different
mechanisms and Vav may also be involved in signaling during platelet
aggregation by its redistribution to the cytoskeleton.
Volume 89,
Issue 8,
pp. 2789-2798,
04/15/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Staerk, C. Lacout, T. Sato, S. O. Smith, W. Vainchenker, and S. N. Constantinescu
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor
Blood,
March 1, 2006;
107(5):
1864 - 1871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Royer, J. Staerk, M. Costuleanu, P. J. Courtoy, and S. N. Constantinescu
Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability
J. Biol. Chem.,
July 22, 2005;
280(29):
27251 - 27261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Campus, P. Lova, A. Bertoni, F. Sinigaglia, C. Balduini, and M. Torti
Thrombopoietin Complements Gi- but Not Gq-dependent Pathways for Integrin {alpha}IIb{beta}3 Activation and Platelet Aggregation
J. Biol. Chem.,
July 1, 2005;
280(26):
24386 - 24395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Jones, J. D. Craik, J. M. Gibbins, and A. W. Poole
Regulation of SHP-1 Tyrosine Phosphatase in Human Platelets by Serine Phosphorylation at Its C Terminus
J. Biol. Chem.,
September 24, 2004;
279(39):
40475 - 40483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Watanabe, H. Nakajima, H. Suzuki, A. Oda, Y. Matsubara, M. Moroi, Y. Terauchi, T. Kadowaki, H. Suzuki, S. Koyasu, et al.
Functional phenotype of phosphoinositide 3-kinase p85{alpha}-null platelets characterized by an impaired response to GP VI stimulation
Blood,
July 15, 2003;
102(2):
541 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Meunier, D. Bordereaux, F. Porteu, S. Gisselbrecht, S. Chretien, and G. Courtois
Cloning and Characterization of a Family of Proteins Associated with Mpl
J. Biol. Chem.,
March 8, 2002;
277(11):
9139 - 9147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Majka, A. Janowska-Wieczorek, J. Ratajczak, M. A. Kowalska, G. Vilaire, Z. K. Pan, M. Honczarenko, L. A. Marquez, M. Poncz, and M. Z. Ratajczak
Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis
Blood,
December 15, 2000;
96(13):
4142 - 4151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hodohara, N. Fujii, N. Yamamoto, and K. Kaushansky
Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK)
Blood,
February 1, 2000;
95(3):
769 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ozaki, A. Oda, H. Wakao, J. Rhodes, B. J. Druker, A. Ishida, M. Wakui, S. Okamoto, K. Morita, M. Handa, et al.
Thrombopoietin Induces Association of Crkl With STAT5 But Not STAT3 in Human Platelets
Blood,
December 15, 1998;
92(12):
4652 - 4662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Oda, H. D. Ochs, B. J. Druker, K. Ozaki, C. Watanabe, M. Handa, Y. Miyakawa, and Y. Ikeda
Collagen Induces Tyrosine Phosphorylation of Wiskott-Aldrich Syndrome Protein in Human Platelets
Blood,
September 15, 1998;
92(6):
1852 - 1858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Lange, U. M. Martens, C. F. Waller, A. R. Moliterno, W. D. Hankins, and J. L. Spivak
Signal Transduction in Platelets from Patients with Polycythemia Vera
N. Engl. J. Med.,
July 9, 1998;
339(2):
127 - 128.
[Full Text]
|
 |
|
|
|